7-150974931-G-C
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PS1_Very_StrongPM1PM2PP2PP3_StrongPP5_Moderate
The NM_000238.4(KCNH2):c.87C>G(p.Phe29Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F29S) has been classified as Uncertain significance.
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- short QT syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- short QT syndrome type 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Brugada syndromeInheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNH2 | NM_000238.4 | c.87C>G | p.Phe29Leu | missense_variant | Exon 2 of 15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KCNH2 | ENST00000262186.10 | c.87C>G | p.Phe29Leu | missense_variant | Exon 2 of 15 | 1 | NM_000238.4 | ENSP00000262186.5 | ||
| KCNH2 | ENST00000713710.1 | c.87C>G | p.Phe29Leu | missense_variant | Exon 2 of 15 | ENSP00000519013.1 | ||||
| KCNH2 | ENST00000532957.5 | n.310C>G | non_coding_transcript_exon_variant | Exon 2 of 9 | 2 | |||||
| KCNH2 | ENST00000713700.1 | n.45C>G | non_coding_transcript_exon_variant | Exon 2 of 9 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Cardiovascular phenotype Pathogenic:1
The p.F29L variant (also known as c.87C>G), located in coding exon 2 of the KCNH2 gene, results from a C to G substitution at nucleotide position 87. The phenylalanine at codon 29 is replaced by leucine, an amino acid with highly similar properties. A different alteration located at the same position, c.87C>A, resulting in the same protein change, has been reported in several long QT syndrome cohorts and sudden unexplained death cohorts (Splawski I et al. Circulation, 2000 Sep;102:1178-85; Tester DJ et al. Heart Rhythm, 2005 May;2:507-17; Winkel BG et al. J Cardiovasc Electrophysiol, 2012 Oct;23:1092-8; Christiansen M et al. BMC Med Genet, 2014 Mar;15:31; Izumi G et al. Pediatr Cardiol, 2016 Jun;37:962-70). Additionally, several in vitro assays have shown that this alteration affects protein function (Chen J et al. J Biol Chem, 1999 Apr;274:10113-8; Gianulis EC et al. J Biol Chem, 2011 Jun;286:22160-9; Harley CA et al. PLoS One, 2012 Mar;7:e32654; Ke Y et al. Biochem J, 2013 Aug;454:69-77; Ng CA et al. Heart Rhythm, 2020 03;17:492-500). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is predicted to be deleterious by BayesDel in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at